Launch sequencing of pharmaceuticals with multiple therapeutic indications: evidence from seven countries
New medicines are increasingly being identified as efficacious across multiple indications. The impact of current pricing and reimbursement policies on launch decisions across these indications remains unclear.
Gespeichert in:
| Hauptverfasser: | , , , |
|---|---|
| Dokumenttyp: | Article (Journal) |
| Sprache: | Englisch |
| Veröffentlicht: |
13 February 2023
|
| In: |
BMC health services research
Year: 2023, Jahrgang: 23, Pages: 1-17 |
| ISSN: | 1472-6963 |
| DOI: | 10.1186/s12913-023-09095-2 |
| Online-Zugang: | Verlag, kostenfrei, Volltext: https://doi.org/10.1186/s12913-023-09095-2
|
| Verfasserangaben: | Mackenzie Mills, Daniel Michaeli, Aurelio Miracolo and Panos Kanavos |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1842855220 | ||
| 003 | DE-627 | ||
| 005 | 20230706213135.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 230417s2023 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1186/s12913-023-09095-2 |2 doi | |
| 035 | |a (DE-627)1842855220 | ||
| 035 | |a (DE-599)KXP1842855220 | ||
| 035 | |a (OCoLC)1389530631 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Mills, Mackenzie |e VerfasserIn |0 (DE-588)1189338823 |0 (DE-627)1668014785 |4 aut | |
| 245 | 1 | 0 | |a Launch sequencing of pharmaceuticals with multiple therapeutic indications |b evidence from seven countries |c Mackenzie Mills, Daniel Michaeli, Aurelio Miracolo and Panos Kanavos |
| 264 | 1 | |c 13 February 2023 | |
| 300 | |a 17 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Gesehen am 17.04.2023 | ||
| 520 | |a New medicines are increasingly being identified as efficacious across multiple indications. The impact of current pricing and reimbursement policies on launch decisions across these indications remains unclear. | ||
| 650 | 4 | |a Clinical Development | |
| 650 | 4 | |a HTA | |
| 650 | 4 | |a Indication-based pricing | |
| 650 | 4 | |a Oncology | |
| 650 | 4 | |a Regulatory Approval | |
| 700 | 1 | |a Michaeli, Daniel |d 1997- |e VerfasserIn |0 (DE-588)1277183244 |0 (DE-627)1830345109 |4 aut | |
| 700 | 1 | |a Miracolo, Aurelio |e VerfasserIn |4 aut | |
| 700 | 1 | |a Kanavos, Panos |d 1964- |e VerfasserIn |0 (DE-588)13358920X |0 (DE-627)549549137 |0 (DE-576)299954323 |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t BMC health services research |d London : BioMed Central, 2001 |g 23(2023), Artikel-ID 150, Seite 1-17 |h Online-Ressource |w (DE-627)331018756 |w (DE-600)2050434-2 |w (DE-576)107014920 |x 1472-6963 |7 nnas |a Launch sequencing of pharmaceuticals with multiple therapeutic indications evidence from seven countries |
| 773 | 1 | 8 | |g volume:23 |g year:2023 |g elocationid:150 |g pages:1-17 |g extent:17 |a Launch sequencing of pharmaceuticals with multiple therapeutic indications evidence from seven countries |
| 856 | 4 | 0 | |u https://doi.org/10.1186/s12913-023-09095-2 |x Verlag |x Resolving-System |z kostenfrei |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20230417 | ||
| 993 | |a Article | ||
| 994 | |a 2023 | ||
| 998 | |g 1277183244 |a Michaeli, Daniel |m 1277183244:Michaeli, Daniel |d 60000 |e 60000PM1277183244 |k 0/60000/ |p 2 | ||
| 999 | |a KXP-PPN1842855220 |e 4309352472 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"id":{"eki":["1842855220"],"doi":["10.1186/s12913-023-09095-2"]},"origin":[{"dateIssuedDisp":"13 February 2023","dateIssuedKey":"2023"}],"name":{"displayForm":["Mackenzie Mills, Daniel Michaeli, Aurelio Miracolo and Panos Kanavos"]},"relHost":[{"language":["eng"],"recId":"331018756","note":["Gesehen am 28.07.2021"],"type":{"bibl":"periodical","media":"Online-Ressource"},"disp":"Launch sequencing of pharmaceuticals with multiple therapeutic indications evidence from seven countriesBMC health services research","part":{"extent":"17","volume":"23","text":"23(2023), Artikel-ID 150, Seite 1-17","pages":"1-17","year":"2023"},"pubHistory":["1.2001 -"],"title":[{"title":"BMC health services research","title_sort":"BMC health services research"}],"physDesc":[{"extent":"Online-Ressource"}],"id":{"issn":["1472-6963"],"zdb":["2050434-2"],"eki":["331018756"]},"origin":[{"publisherPlace":"London","dateIssuedDisp":"2001-","dateIssuedKey":"2001","publisher":"BioMed Central"}]}],"physDesc":[{"extent":"17 S."}],"title":[{"title_sort":"Launch sequencing of pharmaceuticals with multiple therapeutic indications","title":"Launch sequencing of pharmaceuticals with multiple therapeutic indications","subtitle":"evidence from seven countries"}],"person":[{"roleDisplay":"VerfasserIn","display":"Mills, Mackenzie","role":"aut","family":"Mills","given":"Mackenzie"},{"roleDisplay":"VerfasserIn","display":"Michaeli, Daniel","role":"aut","family":"Michaeli","given":"Daniel"},{"display":"Miracolo, Aurelio","roleDisplay":"VerfasserIn","role":"aut","family":"Miracolo","given":"Aurelio"},{"given":"Panos","family":"Kanavos","role":"aut","roleDisplay":"VerfasserIn","display":"Kanavos, Panos"}],"language":["eng"],"recId":"1842855220","type":{"media":"Online-Ressource","bibl":"article-journal"},"note":["Gesehen am 17.04.2023"]} | ||
| SRT | |a MILLSMACKELAUNCHSEQU1320 | ||